drug

Aspirin

MeSH D001241
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Clinic for Psychiatric Disorders, Dr Laza Lazarevic
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Aspirin in Young Psychotic Patients
NCT02685748Phase 2, Phase 3Completed

KOLs & investigators

1
Dragana Pavićević, psychiatrist

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Clinic for Psychiatric Disorders, Dr Laza Lazarevic
company
trial
Aspirin in Young Psychotic Patients
PHASE2, PHASE3
trial
indication
Schizophrenia
indication
Psychosis
indication
Acute Psychosis
indication
Schizophrenia
indication
KOL
Dragana Pavićević, psychiatrist
KOL score —
person